Cancer diagnosis is likely to see a huge resurgence in demand as the pandemic ebbs, and Invitae wants to be ready.
Gamma frequency neuromodulation is the key to treating dementia, according to the MIT spinout.
Pivotal data on its closed-loop insulin delivery system look good, but Medtronic remains a threat.